Avaleht › Ülekaalulisus › Ohio › Cincinnati
Ülekaalulisus kliinilised uuringud linnas Cincinnati, OH
14 uuringut haiguse Ülekaalulisus jaoks otsivad osalejaid linnas Cincinnati ja selle ümbruses (umbes 30 miili raadiuses). Avage uuring, et näha, kes saab osaleda ja kuidas võtta ühendust uuringumeeskonnaga.
Ametlik uuringutekst (inglise keeles)
Otsite osalejaid uuringusse? Esitlege seda selle lehe tipus – $99 30 päeva eest →
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
VärbamineFaas 2
- CTI Clinical Research Center /ID# 282043, Cincinnati
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
VärbamineFaas 3
- Midwest Eye Center, Cincinnati
- Velocity Clinical Research, Mt. Auburn, Cincinnati
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
VärbamineFaas 3
- CTI Clinical Research Center, Cincinnati
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
VärbamineFaas 3
- CTI Clinical Research Center, Cincinnati
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
VärbamineFaas 3
- Velocity Clinical Research - Auburn, Cincinnati
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
VärbamineFaas 2
- CTI Clinical Research Center, Cincinnati
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
VärbamineFaas 3
- AURORA-1 Clinical Site, Cincinnati
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
VärbamineFaas 3
- AURORA-2 Clinical Site, Cincinnati
AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
VärbamineFaas 3
- CTI Clinical Research Center, Cincinnati
AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
VärbamineFaas 3
- CTI Clinical Research Center, Cincinnati
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
VärbamineFaas 2
- CTI Clinical Research Center, Cincinnati
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
VärbamineFaas 3
- Clinical Trial Investigator Clinical Research Center, Cincinnati
- Velocity Clinical Research - Cincinnati, Cincinnati
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
VärbamineFaas 3
- Velocity Clinical Research - Cincinnati, Cincinnati
- Velocity Clinical Research - Springdale, Cincinnati
Effects of Exercise on Lipids and Endothelial Function in Youth
Värbamine
- Cincinnati Children's Hospital Medical Center, Cincinnati
Ülekaalulisus uuringud teistes linnades
- San Antonio, TX34 uuringut
- Houston, TX33 uuringut
- Chicago, IL28 uuringut
- Orlando, FL27 uuringut
- Las Vegas, NV23 uuringut
- Miami, FL23 uuringut
- Atlanta, GA20 uuringut
- Dallas, TX20 uuringut
- New York City, NY19 uuringut
- Jacksonville, FL19 uuringut
- Washington, DC19 uuringut
- Austin, TX18 uuringut
Muud uuringud linnas Cincinnati
- Mitteväikerakuline kopsuvähk35 uuringut
- Vähk (kõik liigid)27 uuringut
- Rinnavähk25 uuringut
- Südamepuudulikkus24 uuringut
- Käär- ja pärasoolevähk21 uuringut
- Äge müeloidne leukeemia20 uuringut
- Metastaatiline vähk20 uuringut
- Munasarjavähk19 uuringut
- Kopsuvähk19 uuringut
- Rasvumine19 uuringut
- Eesnäärmevähk18 uuringut
- Müeloom17 uuringut
Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.